Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

Share Price Information for Creightons (CRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.00
Bid: 23.00
Ask: 27.00
Change: 0.00 (0.00%)
Spread: 4.00 (17.391%)
Open: 25.00
High: 25.00
Low: 25.00
Prev. Close: 25.00
CRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Balance Active Formula

25 Jun 2019 11:54

RNS Number : 3611D
Creightons PLC
25 June 2019
 

25 June 2019

 

Creightons plc ("the Group", "Creightons", the "Company")

Acquisition of Balance Active Formula

 

Creightons plc (CRL), the British-based beauty and well-being brand owner and manufacturer, announces that it has acquired the brand equity, customer list and existing stock of Balance Active Formula ("the Brand") from Brodie and Stone International plc.

 

The acquisition of the performance skincare brand will add to Peterborough-headquartered Creightons' growing range of beauty and well-being products as it continues to expand its brand offering and market presence. Whilst this is a relatively small transaction for the Group, we estimate that it could add an immediate £1.2m to future annual turnover as well as providing the future growth opportunities outlined below.

 

Balance Active Formula is a skincare brand which has built a solid sales base and customer following in the UK market. The acquisition will extend Creightons' reach into the skincare category and to new internet retailing customers as it seeks to grow its on-line offering. The brand's positioning will provide an effective vehicle through which the company can take advantage demand from consumers for performance-led products with new and effective trend ingredients.

 

Manufacturing of the majority of Balance Active Formula products will be moved to Creightons' manufacturing facilities in the UK. 

 

Commenting on the acquisition Creightons' Global Marketing Director, Pippa Clark said: "We are excited by this acquisition which builds on our existing portfolio of brands in the beauty and well-being sectors. It gives us the ability to extend our offering to existing customers and the opportunity to extend our customer base, particularly in export markets. It also offers us even more effective utilisation of our existing sales and manufacturing resources."

 

The acquisition will be funded from the Group's existing cash resources.

 

ENDS

For further information

For Creightons plc

Nick O'Shea, Company Secretary 01733 281000

 

For Analysts and Press

Nigel Szembel/Clive Hunter-Dunne, Anagallis Communications 07802 362088 or nigelszembel@anagallis.co.uk

 

 

Creightons plc

Creightons plc is the one of the United Kingdom's leading manufacturers and brand owners in the beauty, wellbeing and lifestyle sectors. Headquartered in Peterborough, Cambridgeshire, It exports to multiple markets. Brands owned by Creightons include: Feather + Down, BAMbeautiful, The Curl Company and Creightons haircare.

 

Creightons' growing on-line portal can be found at www.creightons.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQSEDFSIFUSELM
Date   Source Headline
15th Mar 202410:52 amRNSBlock listing Interim Review
7th Mar 20247:00 amRNSDirectorate Change
4th Dec 20237:00 amRNSHalf-year Report
27th Nov 20237:00 amRNSDirectorate Change
25th Sep 202311:50 amRNSDirector/PDMR Shareholding
15th Sep 20235:24 pmRNSBlock listing Interim Review
14th Sep 20239:52 amRNSResult of AGM
1st Sep 20235:17 pmRNSDirector/PDMR Shareholding
1st Sep 20235:05 pmRNSDirector/PDMR Shareholding
25th Aug 20233:32 pmRNSDirector/PDMR Shareholding
31st Jul 20232:53 pmRNSReplacement: Director/PDMR Shareholding
24th Jul 202311:54 amRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSAudited preliminary results
31st Mar 202310:49 amRNSTotal Voting Rights
17th Mar 20237:00 amRNSBlock listing Interim Review
16th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Jan 20232:05 pmRNSSecond Price Monitoring Extn
27th Jan 20232:00 pmRNSPrice Monitoring Extension
12th Jan 20232:05 pmRNSSecond Price Monitoring Extn
12th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Dec 202211:05 amRNSSecond Price Monitoring Extn
30th Dec 202211:00 amRNSPrice Monitoring Extension
20th Dec 20224:40 pmRNSSecond Price Monitoring Extn
20th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSHalf-year Report
29th Nov 20224:41 pmRNSSecond Price Monitoring Extn
29th Nov 20224:36 pmRNSPrice Monitoring Extension
25th Nov 20227:00 amRNSInterim Results 2022 - announcement, presentations
27th Sep 20227:00 amRNSUpdate on Emma Hardie, Trading in own shares & TVR
20th Sep 20229:22 amRNSBlock Listing Update
24th Aug 20221:01 pmRNSResult of AGM
12th Jul 20229:05 amRNSSecond Price Monitoring Extn
12th Jul 20229:00 amRNSPrice Monitoring Extension
12th Jul 20227:00 amRNSResults for year to end 31 March 2022
11th Jul 20227:00 amRNSPreliminary Results, investor/analyst presentation
4th Jul 20224:42 pmRNSTotal Voting Rights
7th Jun 20223:28 pmRNSTotal Voting Rights
3rd May 20226:09 pmRNSTotal Voting Rights
12th Apr 20224:33 pmRNSDirector/PDMR Dealing, Total Voting Rights
21st Mar 202211:37 amRNSBlock listing Interim Review
7th Mar 20229:59 amRNSTotal Voting Rights
14th Jan 20222:58 pmRNSTotal Voting Rights
30th Dec 20217:00 amRNSHalf-year Report
15th Dec 20212:52 pmRNSNotice of Interim Results & Investors Presentation
6th Dec 20215:38 pmRNSTotal Voting Rights
25th Nov 20216:18 pmRNSDirector/PDMR Shareholding and Total Voting Rights
23rd Nov 20214:49 pmRNSDirector/PDMR Shareholding
18th Nov 202111:55 amRNSDirector/PDMR Shareholding
17th Nov 20211:58 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.